University of Southern California

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Southern California sits in the top decile of US sponsors by registered trial count (#55 of 15,742 sponsors by registered trial count).

617 total trials 97 currently recruiting 361 completed early-phase tilt top decile by trial count

University of Southern California: 617 sponsored US clinical trials, 97 recruiting.

University of Southern California sponsors 617 registered US clinical trials on ClinicalTrials.gov, 97 of them currently recruiting, and 361 completed. 31 of these trials are in Phase 3-4 (later-stage) and 173 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 6 trials.

Top-decile sponsor footprint

University of Southern California ranks in the top decile of sponsors by registered trial count (#55 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 33/100

361 of 466 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (77.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

617 total, page 6 of 13

TERMINATED NA

Utility of Contrast-Enhanced Sonography and Shear Wave Elastography

NCT04614389

COMPLETED NA

Team-Based Connected Health (TCH) to Improve Clinical Outcomes and Access in Atopic Dermatitis

NCT03981926

COMPLETED NA

Effects of E-Cigarettes in Menthol Smokers

NCT05949034

TERMINATED NA

PK/PD of Vitamin D3 in Adults With CF

NCT03734744

COMPLETED

TRC-PAD Program: In-Clinic Trial-Ready Cohort

NCT04004767

COMPLETED NA

Monitoring and Evaluation of Posture in Office Workstations With Artificial Intelligence

NCT04122326

COMPLETED NA

Encouraging Judicious Prescribing of Opioids in Los Angeles County

NCT03856593

TERMINATED NA

Movement and Fitness Trackers in Determining Performance Status

NCT03971266

COMPLETED NA

Monitoring Physical Activity in Hispanic Women With Chronic Neurological Disorders

NCT04820153

COMPLETED NA

Application of Economics & Social Psychology to Improve Opioid Prescribing Safety (AESOPS): R21 Pilot Phase

NCT03773484

COMPLETED NA

Virtual Reality Study - COVID-19 Protocol

NCT04678778

COMPLETED NA

Mindfulness for at Risk Youth: Understanding Substance Use and Important Mechanisms of Change

NCT04160754

COMPLETED Phase 4

Interscalene Single Shot With Plain Bupivacaine Versus Liposomal Bupivacaine for Arthroscopic Shoulder Surgery

NCT03638960

COMPLETED Phase 1

Effects of Nicotine in Tobacco Smokers

NCT03651869

COMPLETED NA

Effects of e-Cigarettes on Perceptions and Behavior

NCT03742817

COMPLETED Phase 2

Pravastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease

NCT04284657

COMPLETED

The Sweet PEA Study: Effects of Diet During Pregnancy on Infant Growth and Development.

NCT04674033

TERMINATED NA

Nature Video to Improve Older Adult Health: A Feasibility Study.

NCT03722316

COMPLETED Phase 3

Epigenetics and MDMA-Assisted Psychotherapy for PTSD

NCT06189027

TERMINATED

Assessing the Induction of Long-term Immune Regulation Following Treatment With Lemtrada® (Alemtuzumab).

NCT03647722

COMPLETED NA

In-home Obesity Prevention to Reach Low-income Infants

NCT03529695

TERMINATED NA

Group Medical Visits for Latina Women With Urgency Urinary Incontinence

NCT03687164

TERMINATED Phase 2

Mindfulness Training Plus Oxytocin Effects on Smoking Behavior

NCT03819231

COMPLETED NA

Testing Means to Scale Early Childhood Development Interventions in Rural Kenya

NCT03548558

COMPLETED NA

Lactated Ringer's Versus Normal Saline for Acute Pancreatitis

NCT03642769

TERMINATED NA

Betaquik as an Adjunct to Dietary Management of Epilepsy in Adults on the Modified Atkins Diet

NCT03790436

TERMINATED

Detection of MSI in Circulating Tumor DNA of Colorectal Carcinoma Patients

NCT03594448

COMPLETED Phase 2

DHA Brain Delivery Trial

NCT03613844

COMPLETED Early Phase 1

Depot Medroxyprogesterone Acetate as Emergency Contraception

NCT03395756

COMPLETED

Couples Dynamics and Smoking Cessation

NCT03885336

COMPLETED NA

Pilot Sugar Reduction Intervention in Kiritimati Teenagers

NCT04319003

COMPLETED NA

Telemedicine Monitoring of Nocturnal Incidents

NCT04328896

COMPLETED NA

Golf for Healthy Aging

NCT03916887

TERMINATED NA

SMARTfit Training for Parkinson's Disease

NCT03921359

TERMINATED Phase 1

EphB4-HSA Fusion Protein and Cytarabine /or Liposomal Vincristine in Patients With Recurrent or Refractory Acute Leukemia

NCT03519984

COMPLETED NA

Psychosocial Outcomes in Hand Therapy

NCT03458013

COMPLETED NA

A Smartphone App to Improve Physical Activity

NCT03417440

TERMINATED NA

Train Your Brain: Neurofeedback Intervention for PTSD

NCT03858933

COMPLETED NA

A Multidisciplinary Delirium Prevention Strategy Involving Psychiatry in the ICU

NCT03550495

COMPLETED NA

Otteroo Case Series

NCT03502265

COMPLETED

Spatial Frequency Domain Imaging (SFD) for Assessment of Diabetic Foot Ulcer Development and Healing

NCT03341559

TERMINATED Phase 3

5-FU Based Maintenance Therapy in RAS Wild Type Metastatic Colorectal Cancer After Induction With FOLFOX Plus Panitumumab

NCT03300609

TERMINATED NA

Heart Rate Variability and Emotion Regulation

NCT03458910

COMPLETED NA

A Preliminary Clinical Usability Study for the Recovery Force DVT II Cuff

NCT03328624

COMPLETED NA

Sedentary Behavior and Health Outcomes Study

NCT03153930

TERMINATED

Collection of Blood Samples in Patients With Non-small Cell Lung Cancer

NCT03492801

TERMINATED Phase 4

Prunes for Gastrointestinal Function After Gynecologic Surgery

NCT03523715

COMPLETED NA

Feasibility of Delivering a Complex Behavioral Intervention for Young Adults With Diabetes Via Telehealth

NCT03333772

TERMINATED

Collection of Blood in Studying Metabolites in Patients With Prostate Cancer

NCT03485794

TERMINATED Phase 2

IRX-2 Regimen in Treating Women With Cervical Squamous Intraepithelial Neoplasia 3 or Squamous Vulvar Intraepithelial Neoplasia 3

NCT03267680

← Previous Page 6 of 13 Next →

Phase Distribution

PhaseTrial count
Phase 1 83
Phase 2 90
Phase 3 9
Phase 4 22

What is open in the University of Southern California pipeline

97 recruiting of 617 indexed (16% open); 361 completed (59%).

Phase mix: 31 late (III/IV) vs 173 early (I/II) (early-phase heavy).

Top condition: Obesity (6 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Southern California: open-pipeline peers nationwide

Peers matched on 617 registered trials and 16% open enrollment, not the therapeutic-area sidebar.

University of Southern California sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0200400600800 0%5%10%15%20% Total trials Recruiting share University of Southern CaliforniaBaylor College of MedicineUS Department of Veterans AffairsUniversity of RochesterJanssen Research & DevelopmentYoungstown State UniversityRoswell Park Cancer InstituteFox Chase Cancer CenterUniversity of Oregon
University of Southern California sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Southern California sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 617 trials (± recruiting share)

Sponsors near 16% open enrollment (± trial volume)

What to do with this University of Southern California page

617 registered trials is a research-attention snapshot, not an endorsement of University of Southern California or any single study.

  • 97 of University of Southern California's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Obesity is the condition University of Southern California studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Southern California pipeline card: 617 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.